Schedule 13G ownership disclosure
AERPIO PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 00810B105
Event date: 2020-09-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 475,778
- Percent of class
- 1.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-005470
- Form type
- SC 13G
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Jan 11, 2021
- Reporting period
- Sep 18, 2020
- Description
- Schedule 13G beneficial ownership